98%
921
2 minutes
20
Background: Mycophenolic acid (MPA) is a standard immunosuppressant in organ transplantation. A simple monitoring biomarker for MPA treatment has not been established so far. Here, we describe inosine 5'-monophosphate dehydrogenase (IMPDH) monitoring in erythrocytes and its application to kidney allograft recipients.
Methods: IMPDH activity measurements were performed using a high-performance liquid chromatography assay. Based on 4203 IMPDH measurements from 1021 patients, we retrospectively explored the dynamics early after treatment start. In addition, we analyzed the influence of clinically relevant variables on IMPDH activity in a multivariate model using data from 711 stable patients. Associations between IMPDH activity and clinical events were evaluated in hospitalized patients.
Results: We found that IMPDH activity reflects MPA exposure after 8 weeks of constant dosing. In addition to dosage, body mass index, renal function, and coimmunosuppression affected IMPDH activity. Significantly lower IMPDH activities were found in patients with biopsy-proven acute rejection as compared to patients without rejection (median [interquartile range]: 696 [358-1484] versus 1265 [867-1618] pmol xanthosine-5'-monophosphate/h/mg hemoglobin, P < 0.001). The highest IMPDH activities were observed in hospitalized patients with clinically evident MPA toxicity as compared to patients with hospitalization not related to MPA treatment (1548 [1021-2270] versus 1072 [707-1439] pmol xanthosine-5'-monophosphate/h/mg hemoglobin; P < 0.001). Receiver operating characteristic curve analyses underlined the usefulness of IMPDH to predict rejection episodes (area, 0.662; confidence interval, 0.584-0.740; P < 0.001) and MPA-associated adverse events (area, 0.632; confidence interval, 0.581-0.683; P < 0.001), respectively.
Conclusions: IMPDH measurement in erythrocytes is a novel and useful strategy for the longitudinal monitoring of MPA treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/TP.0000000000003336 | DOI Listing |
Ann Med
December 2025
Department of Dermatology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
Background: Vitiligo is a depigmentation disorder with an undefined specific pathogenesis, with the autoimmune theory being a prominent etiology. Mycophenolate mofetil (MMF), a novel immunosuppressant, selectively inhibits inosine 5-monophosphate dehydrogenase (IMPDH), crucial for lymphocyte DNA synthesis. Recent research has highlighted MMF's efficacy in vitiligo treatment; however, the precise mechanism remains unclear.
View Article and Find Full Text PDFSci Rep
July 2025
Department of Organic Chemistry, Faculty of Chemistry, Gdańsk University of Technology, ul. G. Narutowicza 11/12, Gdańsk, 80-233, Poland.
Naturally occurring phenols were incorporated into the mycophenolic acid (MPA) core to form sixteen new MPA derivatives. Ester conjugates of MPA with isoeugenol, methyl o-coumarate, and raspberry ketone exhibited the highest antioxidant activity in the DPPH test. These derivatives were then tested against the human pancreatic cancer AsPC-1 cells, showing cytotoxicity similar to that of the referential parent compounds MPA and mycophenolate mofetil (MMF).
View Article and Find Full Text PDFMol Biotechnol
July 2025
Institute of Biochemistry and Biophysics, University of Tehran, Tehran, 1417614335, Iran.
Inosine monophosphate dehydrogenase (IMPDH) catalyzes the rate-limiting step of GTP biosynthesis. The multilevel regulation of the enzyme complicates its inhibition to treat diseases such as retinitis pigmentosa (RP) where modulation of the isozyme IMPDH1 is disrupted by mutations in a GTP-binding site on its regulatory CBS domain. Here, we hypothesize that upsetting the ATP-binding site 1 on the CBS domain, which contributes to all levels of the enzyme regulation, can endow it with the conformational features characteristic of the inhibited form of IMPDH1.
View Article and Find Full Text PDFmedRxiv
June 2025
Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Background: Classified by the WHO as one of the 19 most dangerous fungal pathogens, has been associated with increasing outbreaks of pneumonia (PCP) among solid organ transplant (SOT) recipients worldwide. Mycophenolic acid (MPA), an inosine monophosphate dehydrogenase (IMPDH) inhibitor commonly used as an immunosuppressant to prevent organ rejection, is a risk factor for PCP. However, MPA also displays antifungal activity, potentially protecting against PCP, despite not being used to treat it.
View Article and Find Full Text PDFJ Hazard Mater
September 2025
MOE Key Laboratory of Resources and Environmental Systems Optimization, College of Environmental Science and Engineering, North China Electric Power University, Beijing 102206, China. Electronic address:
Co-exposure to low-density polyethylene microplastics (LDPE-MPs) and plastic additives like bisphenol A (BPA) and bisphenol AF (BPAF) poses a growing concern in aquatic environments, yet the role of LDPE-MPs in modulating their toxicity remains debated. This study integrates transcriptome sequencing, adsorption/desorption kinetics, and computational toxicology to assess how LDPE-MPs influence BPA- and BPAF-induced toxicity in zebrafish. We found that BPAF is more toxic than BPA, with 96 h lethal concentration 50 % (LC) values of 1.
View Article and Find Full Text PDF